accès équitable
acces to medicines
acceso
access - child‐specific medicines
access to health technologies
access to medicines
access to medicines for children
access to new and existing pharmaceutical products
Access to Opioid Medications in Europe (ATOME)
access to technology
accessibility
acquisition
action plan
Active Pharmaceutical Ingredient - API
acupuncture
adherence
adherence to guidelines
adherence to treatment
adverse drug reactions
adverse drug reactions monitoring
adverse event (AE)
advertisement and promotion
advertising
advocacy
affordability
affordability of medicines - measurement practical methods
Affordable Medicines Facility - malaria (AMFm)
African Health Observatory
Alma-Ata conference
alternative medicine
analgésiques opioïdes
analytical method transfer
annual report
anti-bacterial agents - administration and dosage
anti-HIV activity
anti-infective agents - adverse effects
anti-tuberculosis medicines
antibacterial
antibiotic
antibiotic policy
antibiotic prophylaxis
antibiotic resistance
antibiotics - non prescribed use
antibiotics - use
antibiotics - veterinary
antibiotics control
antimalarial drug resistance
antimalarial medicines
antimalarial treatment policy
Antimalarials – standards
antimicrobial
antimicrobial containment
antimicrobial resistance (AMR)
antimicrobial resistance surveillance
antimicrobiens
antiretroviral therapy (ART)
antiretroviral treatment
antiretrovirals
antirétroviraux (ARV)
antivenoms
appropriate use
ART programme
ART regimens and formulations
Artemisinin based Combination Therapies (ACT)
artemisinin resistance
artemisinin-based monotherapy (oral)
ARV drugs
assessing medicines
assessment
assurance-qualité du médicament
asthma
Asthma Drug Facility (ADF)
asthma medicines
ATC/DDD Classification
atención farmacéutica
autorisation de mise sur le marché
autorités de réglementation
availability
avian influenza
bacterial infections
banned products
basic tests
benzodiazepines
biennial report
bilan
bioequivalent generic products
biological and biotechnological substances
biological products
biological standardization
biomedical technology
blood chain - collection, processing and distribution
blood establishments
blood products
Boa Prescrição Médica
bonnes pratiques pour les achats
Botiquín Médico Interinstitucional de Emergencia (BMIE)
brief
bulk purchasing systems
case study
child dosage form
children
children - management of common illnesses
children - management of diarrhoea
children - management of pneumonia
children - quality of care
child‐specific medicines
chiropractic
chronic disease
chronic disease medicines
chronic illness
clinical effectiveness
clinical evaluation
clinical guidelines
clinical pharmacology and research
clinical standards and protocols
clinical trials
clinical trials on treatment
co-payment
collaboration with countries
Comité Pharmaceutique et Thérapeutique (CPT)
community
community financing
community-based health insurance (CBHI)
comparative analysis
complementary medicine
compliance with guidelines
compulsory licence
computerized logistic support system
concepts and definitions
conference
conservation
constitutions
consumer
consumption
consumption method
contaminants
control
contrôle des drogues
contrôle des stupéfiants
controlled clinical trials
controlled medications
controlled medications programme
controlled medicines
controlled substances
coopération pharmaceutique
coordinators
corruption
cost - treatment
cost containment
cost-benefit analysis
cost-effectiveness
Cost-sharing
cotrimoxazole
counterfeit drugs
Country Cooperation Strategy (CCS)
country data profile
course
curricular development
data collection
decentralization
definitions
degradable substances
dépôt de produits pharmaceutiques
developing countries
diabetes
diabetes medicines
Diabetes Mellitus (DM)
diagnosis
diagnostic
diagnostic - methods
diagnostic tests
diagnostics assessment
disease control priorities
dispensing
disposal methods
distribution
distribution and storage system
distribution chain
distribution practices
distribution processes - pharmaceutical products
DOHA Declaration
domaine pharmaceutique
domestic production - essential medicines
donation of medical supplies
donations
donations of medical equipment
donors
dosage
dosage regimens
Drug Act
drug action programme
Drug and Therapeutics Committee - DTC
drug bulletin
drug consumption
drug conventions
drug costs
drug dependence
drug distribution
drug donation practices
drug donations
drug dosage information
drug evaluation
Drug expenditure
drug financing
drug information
drug monitoring
Drug Policy
drug promotion
drug ration kits
drug registration
drug regulation
drug regulatory authorities
drug requirements
drug resistance surveillance
drug resistance, microbial
drug side effects
drug situation analysis
drug supply
drug susceptibility testing
drug testing
drug therapy in the elderly
drug treatment
drug treatment - old age
drug use
drug utilization
Drug-resistant tuberculosis (DR-TB)
drugs
EC/ACP/WHO partnership program
economics, pharmaceutical
EDM series
education
effets indésirables
efficacy
elderly people
emergency
emergency drugs
Emergency Health Kit (IEHK)
enregistrement
enregistrement des médicaments essentiels
equitable access
equity
Essential Medical Devices
essential medicines - concept
essential medicines - history
Essential Medicines List for children - EMLc
essential medicines/drugs
essential medicines/drugs list
estrategia OMS
ethical criteria
ethical infrastructure
ethical practices and standards
ethics
EU medicines regulation
evaluation
evaluation of substances
evaluation studies
evidence
evidence - effectiveness and efficiency
evidence-based health information
evidence-based medicine (EBM)
expenditure on medicines (public and private sectors)
facility surveys
fact book
faith based organisations
fake drugs
field testing
financial and economic global crisis
financial resources for medicines
financing
finished pharmaceutical products - FPPs
fixed-dose combination
food safety
formulary
fourniture international des médicaments
funding mechanisms
gender perspective
general
General Agreement on Trade in Services (GATS)
general practice
general practitioner - role and functions
generic drug policies
generic medicines
generics
global burden
global economic crisis
global medicines activities
Global Price Reporting Mechanism - GPRM
globalization
glossary
Good Agricultural and Collection Practices (GACP)
Good Clinical Practice (GCP)
Good Distribution Practices (GDP)
good governance
Good Manufacturing Practices (GMP)
Good Pharmaceutical Procurement
Good Pharmacovigilance Practice
good pharmacy practice - GPP
Good practices for national pharmaceutical control laboratories (GPCL)
Good practices for pharmaceutical
Good practices for pharmaceutical quality control laboratories (GPCL)
good practices in production
good practices in quality control
Good Prescribing Practice (GPP)
Good Regulatory Practice (GRP)
good storage practices
governmental Programs
group of pharmaceutical substances
groups of of biological products
guide for teaching
guidelines
guidelines and standards
guidelines review
A (H5N1) virus
harmonization
health care
health care equipement donations
health care reform
health care surveys
health commodities
health economics
health expenditures
health expenditures - out of pocket
health facilities
health facility surveys
health financing
health for all
health indicators
health information
health information products
health information system
health innovation cycle
health insurance
health insurance systems
health plan implementation
health planning
health policy
Health Policy and Systems Research (HPSR)
health priorities
health profile
health reform
health sector
health services
health services evaluation
health statistics
health system
health system building blocks
health system strengthening
health systems
health technology assessment (HTA)
health workers
health workers situation
health-care procurement
healthcare facilities
Heating, Ventilation and Air Conditioning (HVAC)
herbal medicines
history
HIV prevention
HIV-infected infants and children
HIV-related infections
HIV/AIDS
HIV/AIDS policy
HIV/AIDS related treatment
HIV/AIDS-related drugs
homeopathic medicines
homeopathy
homologation
hospital
hospital care
hospital care for children
hospital pharmacy
household survey
human resource development (HRD) policy
human resources
human resources for health - distribution
human resources for health - HRH
human rights
humanitarian aid
implementation
import/export authorisation
IMS data collection
inappropriate use
indicator-based approach
indicators
indicators-based approach
industrial policy
industry
infections with bloodborne pathogens
infectious diseases
information
information exchange
information to patients
information, education, and communication (IEC)
informes técnicos
infrared reference spectra
injectable oxytocics
injection
injections safety
INN - biological and biotechnological substances
INN - names for radicals and groups
innovation
Innovation and intellectual property
inocuidad en quiropráctica
inspections
insulin
insurance
insurance coverage
integrated antimicrobials for human medicine
intellectual property
Intellectual Property Rights
Inter-agency coordination
inter-regional collaboration
interactions with countries
Interagency List
international bidding
international commerce
International Conference on Harmonisation (ICH)
international drug monitoring
international harmonization
international health
International Nonproprietary Names (INN)
International Pharmacopoeia (The)
international standards
international strategies
international treaties
internet
inventory management
IP enforcement measures
kit programmes
kit sanitaire d’urgence
kit systems
laboratory evaluations
laboratory practices - international harmonization
laboratory quality of medicines
laboratory supplies and equipment
Legal framework
legislation
legislative framework
lexicon
licensing
liste inter-institutions
Liste nationale des médicaments essentiels
literature review
local manufacture of pharmaceuticals
local pharmaceutical industry
local production
local production - diagnostics
local production - essential medicines for children
local production - medical technologies
long-term therapies
low- and middle-income countries
maintenance activities
malaria
malaria - diagnosis
malaria - microscopy
malaria - parasite-based diagnosis
malaria treatment policy
management of drugs
manual therapies
marché pharmaceutique
market control
marketing authorization
marketing practices
massage
measurement
medical devices
medical equipment
medical practice
medical products
medical technologies
médicaments importés
médicaments sous contrôle
medication errors
medicinal drug
medicinal plants
medicinal products
medicine distribution
medicine donations
Medicine Expenditures
medicine prices
medicine regulation
medicine supply
medicine supply shortages
medicines for acute conditions
medicines for children
medicines for maternal and child health
medicines for mothers
medicines list
medicines management cycle
medicines policy
medicines policy - support
medicines policy development
medicines price information
medicines registration
medicines regulation
medicines regulatory authority (MRA)
medicines regulatory authority (MRA) - announcements
medicines strategy
medicines use - patterns and trends
mental health
MeTa - The Medicines Transparency Alliance
méthodologiques pour la recherche
microbiology laboratories
microscopy
Mini Emergency Health Kit (MEHK)
misuse of prescription medicines
monitor
monitoring
monocomponent products
monographs
morbidity
multidrug-resistant organisms - MDROs
Multidrug-resistant Tuberculosis (MDR-TB)
multisource (generic) products
narcotic drugs
Narcotics Control
national constitutions
national drug information
national drug list
national drug regulation
national essential drug programmes
national formulary
national framework
national health care programme
national health observatories
national medicines list
National Medicines Regulatory Authority (NMRA)
national medicines/drugs policy
national pharmaceutical systems
national policy
national strategies
national treatment guidelines
national tuberculosis control programmes
natural products
naturopathy
NCDs - cost-effective intervention strategies
NCDs - costs
NCDs - economic burden
needles and syringes
Nevirapine
new technologies
newsletter
NIS - Newly independent states of the former Soviet Union
nomenclature process
noncommunicable disease
nonprescription medicines
nonproprietary names
nosocomial
Nuad Thai
off-patented medicines
old age
operational principles
opioid analgesics
opioïde
opioids
opioids control
oral oxytocics
orphan drugs
osteopathy
Out-of-pocket spending (OOP)
paediatric dosage forms
paediatric formulations
paediatric health care
paediatric medicines
Paediatric Medicines Regulatory Network
paediatrics
pain - pharmacological management
pain management
pain management in children
pain treatment
palliative care
Paris Convention
partnership
patent information
patent infringement
patent system
patents
patient care
Pediatric medicines Regulatory Network
people living with HIV/AIDS
performance assessment
pharmaceutical assessment
Pharmaceutical Business Plan
pharmaceutical care
pharmaceutical consumption
pharmaceutical data
pharmaceutical expenditure
pharmaceutical gaps
pharmaceutical human resources
pharmaceutical industry
pharmaceutical innovation
pharmaceutical market
pharmaceutical microbiology laboratories
pharmaceutical policies
pharmaceutical preparations
pharmaceutical preparations - standards
pharmaceutical prepations
pharmaceutical prices
pharmaceutical pricing
pharmaceutical production
pharmaceutical products
pharmaceutical profile
pharmaceutical promotion
pharmaceutical sector
pharmaceutical services
pharmaceutical situation
Pharmaceutical Situation Assessment (PSA)
pharmaceutical substances
pharmaceutical supply
pharmaceutical supply chain
pharmaceutical system
pharmaceuticals
pharmaceuticals newsletter
pharmaceuticals programme
pharmacist
pharmacoepidemiology
pharmacokinetics
pharmacopoeia
pharmacotherapy
pharmacovigilance
pharmacovigilance guideline
pharmacovigilance systems
Pharmacovigilance Toolkit
pharmacy curricula
pharmacy practice
pharmacy workforce
PHC–based health systems
physicians
pioglitazone
planning resources
plasma derivatives
policy
policy developments
policy implementation
policy perspectives
pooled procurement
post marketing surveillance
potency of drugs
práctica de farmacia
Práticas da Boa Prescrição Médica
pratiques éthiques
Praziquantel
pre-marketing evaluation
preparaciones farmacéuticas
préparations à base de plantes
prequalification of diagnostics
Prequalification of diagnostics, medicines and vaccines - WHO
prequalification of medicines
Prequalification of Medicines Programme - WHO
prequalification of Quality Control Laboratories
prequalification of suppliers
prequalified product dossier
prescribers
prescribing
prescribing pattern
prescribing practices
price - retail / retail pricing
price comparison
price measurement tool
price medicines (ARVs) - transaction/quantities
price negotiations
price of treatment
price trend - ARVs
prices / pricing policy
prices (patient price)
prices (procurement price)
pricing mechanisms
pricing methodology
pricing models for pharmaceuticals
primary care
primary health care
primary health care (PHC)
priority medicines
private health insurance
private-sector retail pharmacy
procedure for prequalification of pharmaceutical products
procurement
procurement - procedures & processes
procurement - public sector
procurement - RDTs for malaria
procurement agencies
procurement of medicines
procurement of medicines - Public sector
product assessment
product testing - malaria RDTs
production
products not approved
produits biologiques
programme activities
programmes de formation
progress
promotion
proper use
propriété intellectuelle
psychiatrists
psychoactive substances
psychotropic drugs
psychotropic substance
public and private sectors
public education
public health
public pharmaceutical sector
public tendering
public-private roles
purchasing and inventory control
QAMSA - Quality of Antimalarials in Sub-Saharan Africa
quality
quality assessment procedure
quality assurance
quality assurance of antiretrovirals
quality assurance system
quality control
quality control - lot testing
quality control laboratories
quality of care
quality of paediatric care in hospitals
quality standards
quality tests - medicines
quantification - forecasting of medicines and supplies
Questionnaires
rabies
rapid diagnostic test (RDT)
rapport de situation
rare diseases
rational prescribing
rational use
readership survey
reference list
reference substances
reform
registration
registration of pharmaceuticals
registration of vaccines
regulation
regulatory agencies
regulatory assessment
regulatory authority - medicines
regulatory control
regulatory information
regulatory institutional capacity
regulatory matters
regulatory requirements
regulatory systems
reimbursement
reliable information
remuneration
report
reporting
reporting - consumer reporting system
reporting system
reproductive and sexual health
reproductive health
reproductive health medicines
research
research and development
Research and training
residues
resistance containment
resource limited settings
resource-poor countries
restrictions in use
review
Revolving Drug Funds (RDFs)
right to health
risk/benefit ratio
safe disposal of pharmaceuticals
safe trade
safety
safety - vaccine
sampling studies
secteur pharmaceutique privé commercial
secteurs public et privé
selection
selection criteria
selection of drugs
selection of medicines
selection process
self inspections
self-care
self-medication
sexually transmitted infections
shortages of medicines
side effect
SIGNAL - Uppsala Monitoring Centre's SIGNAL
signals - (Drug safety/Clinical trials)
single-source pharmaceuticals
single-use injection equipment
situación reglamentaria
situation analysis
situation de ressources limitées
snake antivenom immunoglobulins
snake antivenoms
snake bites
snake venoms
social health insurance
soins médicaux d'urgence
sorting categories
sources
Southern African Development Community (SADC)
specifications
stability
stability testing
stability tests
staff
Standard
standard methods
standard treatment
standard treatment guidelines
standards of practice
Standards Operating Procedures (SOP)
statistics
statistics - Pharmaceutical
stems
stock management
storage
storage of essential medicines
Strategic Plan
strategies
students
study
stupéfiants
substance abuse
substances psychotropes
substances sous contrôle
substandard drugs
suppliers
supply
supply agencies
supply chains
supply management
supply system
surveillance
sustainable access
taxation of medicines
TB treatment policies
teaching of pharmacotherapy
technical assistance
technical support
technology assessment, biomedical
technology transfer
technology transfer - public policies
terminology
terms
testing
tests
tests simplifiés
therapeutic information
thin-layer chromatography (TLC)
time- and temperature-sensitive pharmaceutical products (TTSPPs)
total health expenditure (THE)
total pharmaceutical expenditure (TPE)
trade
Trade Related Aspects of the Intellectual Property Rights (TRIPS)
Traditional Chinese medicine (TCM)
traditional medicine
traditional practitioners
traditional remedies
training
transfer of technology
transmission of HIV
transparence
transparency
transport volume - estimation
transportation
treatment
treatment - children
treatment - malaria
treatment guidelines
treatment of pain
treatment protocols
treatment regimens
treatment strategy
treatments - mental disorders
TRIPS Agreement
TRIPS flexibilities
tropical disease treatments
tuberculosis
Tuina
Unani medicine
universal access to essential medicines
universal coverage of services
use
use of essential drugs
use of medicines
use of medicines in children
use of stems
utilization
vaccines
validation studies
validation, water, air handling systems
venomous snakes
venoms and antivenoms
vitamins
in vitro screening
voluntary agreements
voluntary licences
warehouse
web sites
WHO Advisory Committee on Safety of Medicinal Products (ACSoMP)
WHO AMR
WHO certification scheme
WHO collaborating centres
WHO expert committee
WHO International Drug Monitoring Programme
WHO model formulary
WHO model list
WHO monograph
WHO Rapid Alerts
WHO training modules
WHO/HAI methodology
withdrawn products
workforce
world medicine situation
WTO Agreements